Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MET receptor is overexpressed but not mutated in oral squamous cell carcinomas.

Journal of cellular physiology - 1 Dec 2001

Morello S, Olivero M, Aimetti M, Bernardi M, Berrone S, Di Renzo M F, Giordano S

Abstract excerpt

Oral squamous cell carcinoma (SCC) is a neoplasm characterized by a high degree of local invasion and an elevated rate of metastasis to cervical lymph nodes. It has been shown that the Hepatocyte Growth Factor/Scatter Factor Receptor Met is constitutively activated in many human tumors of epithelial origin and that it plays a critical role to confer invasive properties to neoplastic cells. Most frequently, Met...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blotting, Western
Share to Carcinoma, Squamous Cell

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mouth Neoplasms

Share to Neoplasm Invasiveness

Share to Phosphorylation

Share to Proto-Oncogene Proteins c-met

Share to RNA, Neoplasm

Share to Tumor Cells, Cultured

Source

Identifiers

PMID: 11748586
DOI: 10.1002/jcp.10010

Genes

MET
HGF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MET receptor is overexpressed but not mutated in oral squamous cell carcinomas.PMID 11748586Read ↗

Understanding c-MET signalling in squamous cell carcinoma of the head & neckSemantic proximity Read ↗

Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas.Semantic proximity Read ↗

Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas.Semantic proximity Read ↗

The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.Semantic proximity Read ↗

Role of c-MET in upper aerodigestive malignancies--from biology to novel therapies.Semantic proximity Read ↗

Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunitiesSemantic proximity Read ↗

Expression and mutational analysis of MET in human solid cancers.Semantic proximity Read ↗

Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases.Semantic proximity Read ↗

Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion.Semantic proximity Read ↗

Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancerSemantic proximity Read ↗

Retrospective review of MET gene mutationsSemantic proximity Read ↗

MET genetic abnormalities unreliable for patient selection for therapeutic intervention in oropharyngeal squamous cell carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.